Answers are grounded in this paper and cite their sources.
Corrigendum reports corrected wound healing complications in patients using GLP-1 receptor agonists after explantation.
The authors regret that a transcription error was introduced in the Abstract and Table 3 in the reporting of wound healing complications of patients using GLP-1 receptor agonists. The correct values, as stated in the Results section, are 5/30 (16.7%) in the GLP-1 group versus 2/30 (6.7%) in the control group (p=0.42, OR 2.78, 95% CI 0.49–15.7). The Abstract and Table 3 incorrectly reported 4/30 (13.3%) versus 1/30 (3.3%) (p=0.35, OR 4.46, 95% CI 0.47–42.1). As defined in the Methods and Results sections, wound healing complications comprise wound dehiscence (GLP-1: 1/30; Control: 0/30) and fat necrosis (GLP-1: 4/30; Control: 2/30) combined.
No takes yet. Share an insight, caveat, or question.
Friedman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: